ClinicalTrials.gg
CompletedNCT03634709Updated Jun 17, 2020

Autobiographical Memory Flexibility Training (MemFlex) for Posttraumatic Stress Disorder

An interventional study of Memory Flexibility training (MemFlex) in Post Traumatic Stress Disorder, sponsored by Medical Research Council Cognition and Brain Sciences Unit. Completed at 1 site in Iran, Islamic Republic of. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2020-06-17.

Sponsored by Medical Research Council Cognition and Brain Sciences Unit · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

The experience of trauma not only impacts the way an individual thinks and feels, but can also produce changes in the way someone remembers their personal past. It is not only memories of the trauma that are affected- avoidance of trauma memories can also lead to memories of other events becoming vague, and in particular, memories of positive experiences can seem out of reach. This memory difficulty promotes posttraumatic stress disorder (PTSD). This study will explore an intervention that aims to improve memory difficulties, which should then flow on to improve PTSD. The study will be completed with individuals who have experienced a single incident trauma. Twenty five participants will complete MemFlex straight away, and 25 will go on a waiting list. Once this first group has finished MemFlex, the researchers will compare the two groups to see if the programme produced a larger reduction in PTSD symptoms. MemFlex is workbook-based, and as such, if it is successful it may offer an easy, cheap, and accessible way to offer psychological treatment to PTSD sufferers around the world.

02

Conditions studied

  • Post Traumatic Stress Disorder
03

In context

Stress Disorders, Post-Traumatic

2,682 studies on the registry are indexed under Stress Disorders, Post-Traumatic; 601 are open to participants now.

This study's enrollment of 40 is below the median of 69 across 2,196 interventional studies indexed under Stress Disorders, Post-Traumatic.

Browse Stress Disorders, Post-Traumatic studies →

Lead sponsor

Medical Research Council Cognition and Brain Sciences Unit is the lead sponsor of 8 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Diagnosis of Posttraumatic Stress Disorder (as indexed by the Farsi version of the Structured Clinical Interview for DSM disorders [SCID])
  • Aged over 18 years

Exclusion criteria

Exclusion Criteria:

  • Lack of oral and/or written fluency in Farsi
  • Traumatic brain injury or cognitive impairment, indexed via self-report
  • Current experience of psychosis, indexed by SCID
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
40 participants (actual)

Study arms

  • Experimental
    Memory Flexibility Training (MemFlex)

    The MemFlex programme has been adapted from the initial format addressing depression-related memory distortions to facilitate completion with individuals experiencing posttraumatic stress. The workbook and associated materials have also been translated from English to Farsi. The programme consists of one researcher-facilitated session and eight self-guided workbook-based sessions that train memory retrieval skills and are completed over a one month period.

    Behavioral: Memory Flexibility training (MemFlex)

  • No intervention
    Waitlist control

    After randomisation, the waitlist control group will be informed that they have been placed on a waiting list for the intervention. The participants will complete the baseline assessment and receive no further contact from the researcher until the post assessment one month later, followed by the follow-up assessment three months later. After the three month assessment, wait listed participants will receive the intervention. No further assessments will be completed.

Interventions

  • BehavioralMemory Flexibility training (MemFlex)

    MemFlex is a primarily self-guided, paper workbook-based program which aims to reduce overgeneral memory bias and improve recall of positive, specific event memories. Prior to completing one month of self-guided, workbook-based intervention, the participant will attend one 45 minute face-to-face session in which the facilitator outlines the importance of autobiographical memory in everyday life, discusses the impact of trauma on autobiographical memory, and provides information on the different types of autobiographical memories (e.g., specific, general) and their potential everyday functions. The session also introduces the cued-recall tasks which were used to train the memory skills throughout the workbook, and provides facilitator-assisted practice with the tasks. Once participants are comfortable with the training exercises, they set a schedule for completion of the eight-session workbook over the following four weeks.

06

What researchers measure

Primary outcomes

  1. Autobiographical memory

    Number of correct responses on the Alternating Instructions Autobiographical Memory Test- Farsi version

    Time frame: At post-intervention assessment (approximately 4-5 weeks after pre-intervention assessment)

Secondary outcomes

  1. PTSD symptoms at post-intervention

    Total score (range - 0-80) on the Farsi version of the Posttraumatic Stress Disorder Checklist for the Diagnostic and Statistical Manual of Mental Disorders- Fifth Edition

    Time frame: At post-intervention assessment (approximately 4-5 weeks after pre-intervention assessment)

  2. PTSD symptoms at follow-up

    Total score (range - 0-80) on the Farsi version of the Posttraumatic Stress Disorder Checklist for the Diagnostic and Statistical Manual of Mental Disorders- Fifth Edition

    Time frame: Three months following the completion of the intervention

Other outcomes

  1. Posttraumatic Cognitions

    Total score (range = 33-231) on the Farsi version of the Posttraumatic Cognitions Inventory

    Time frame: At post-intervention assessment (approximately 4-5 weeks after pre-intervention assessment)

  2. Trauma memory quality

    Total score (range = 14-56) on the Farsi version of the Trauma Memory Quality Questionnaire

    Time frame: At post-intervention assessment (approximately 4-5 weeks after pre-intervention assessment)

  3. Rumination

    Total score (range = 22-88) on the Farsi version of the Ruminative Response Scale

    Time frame: At post-intervention assessment (approximately 4-5 weeks after pre-intervention assessment)

  4. Depression

    Total score (range = 0-63) on the Farsi version of the Beck Depression Inventory II

    Time frame: At post-intervention assessment (approximately 4-5 weeks after pre-intervention assessment)

  5. Future Thinking

    Number of generated positive items on the Farsi version of the Future Thinking Task

    Time frame: At post-intervention assessment (approximately 4-5 weeks after pre-intervention assessment)

07

Study locations

1 site
  • Institute for Cognitive Science Studies
    Tehran, Iran, Islamic Republic of
08

References and documents

Individual participant data

Plan to share: Yes — De-identified dataset will be made available online and linked to the published results

Supporting information: Study protocol, Statistical analysis plan, Analytic code

Time frame: At time of publication of peer-reviewed manuscript

Access criteria: Open access

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Aug 2018 to primary completion in Feb 2020, 17 months.

Of 1,064 non-industry interventional studies with no phase under Stress Disorders, Post-Traumatic, half reached primary completion within 35 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 53. This study's 17 months is below that.

Counting every sponsor, half of 1,092 studies reached it within 34 months; a quarter within 17 and three quarters within 53.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 23, 2018
First posted
Aug 16, 2018
StartActual
Aug 19, 2018
Primary completionActual
Feb 11, 2020
CompletionActual
May 11, 2020
Last update
Jun 17, 2020
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 17, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03634709
Lead sponsor
Medical Research Council Cognition and Brain Sciences Unit
Collaborators
Institute for Cognitive Science Studies, Iran, Kharazmi University
Responsible party
Caitlin Hitchcock (Senior Scientist, Medical Research Council Cognition and Brain Sciences Unit) — Principal investigator
First posted
Aug 16, 2018
Start date
Aug 19, 2018
Primary completion
Feb 11, 2020
Completion
May 11, 2020
Last update
Jun 17, 2020

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion